Webinar – Rare & Null Allele Detection with HLA Twin™

Are you interested in Orthogonal Bioinformatic Validation?  

 Watch this latest webinar presentation on HLA Twin™ – Rare & Null Allele Detection

 

Date: Thursday, 11th December, 2014
Time: 12:00–1pm EST (6–7pm CET)
A live Q&A session will follow the presentation, offering you the opportunity to put forward any questions. Following registration, you will receive a confirmation email containing information for joining this event. This Webinar will be recorded and material is available on request.

 Webinar Content

  • Introduction to Holotype HLA
  • HLA Twin Genotyping Software Overview
  • Null Allele Detection (with HLA Twin)
  • Handling Rare Alleles (with HLA Twin)
  • Summary & Benefits
  • Live Q&A Session
Presenters
Tim Hague (CEO)
A passionate biotechnology executive combining a science education with a strong IT background. Tim joined Omixon as a Software Architect before swiftly taking on the role of CTO, a position he held for more than 3 years. In 2013 he became Omixon’s CEO, adding world-wide responsibility for sales, marketing, HR and finances to his existing leadership of research and development. Before joining Omixon, he accumulated 15 years of software engineering and design expertise as Architect/Design Lead at Lufthansa Systems, Technical Consultant at iE and Technical Team Leader at IBM, among others. Tim received a BSc in Genetics from Nottingham University and an MSc in Information Systems Design from the University of Westminster.
Craig Funnell (Director, Sales & Marketing)
Experienced international Sales, Business Development and Marketing Executive. Before moving to Life Science, Craig spent almost 20 years in the Professional Services sector, holding regional management positions with Aon Risk Solutions EMEA (Europe Middle East & Africa). Since 2010 Craig has been a Management Consultant, involved with a number of term projects; Information Technology, Engineering, Hi Tech and Life Sciences – including; Interim CEO of Dyntell Software, Interim CEO of ThalesNano Nanotechnology Inc, consultant for DAVID Spine Clinic and ChemAxon Cheminformatics. Craig initially joined Omixon with a Sales & Marketing consultancy role, and now heads up our worldwide Revenue Generation efforts.
Agnes Pasztor (Customer Support Manager)
Agnes has vocational training in Economical Informatics and is currently studying towards a Bsc in Biology. Experienced software tester with background in banking environments and testing automation. At Omixon, Agnes is responsible for customer support and application testing. Live Q&A session will be presented by her.

Save your seat and register here